You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Paxlovid

Showing 1 - 25 of 49
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

COVID-19 Trial (paxlovid, No paxlovid, Paxlovid)

Not yet recruiting
  • COVID-19
  • paxlovid
  • +2 more
  • (no location specified)
Mar 28, 2023

Efficacy of Azvudine and Paxlovid in Treatment of Hospitalized

Not yet recruiting
  • Paxlovid
  • +2 more
    • (no location specified)
    Aug 16, 2023

    Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19 Trial (Nirmatrelvir/ritonavir, Placebo)

    Not yet recruiting
    • Post COVID-19 Condition, Unspecified
    • +2 more
    • (no location specified)
    May 9, 2023

    COVID-19, Quality of Care Trial in Oakland (Pharmacist Care, AFM Pool Care)

    Not yet recruiting
    • COVID-19
    • Quality of Care
    • Pharmacist Care
    • AFM Pool Care
    • Oakland, California
      Kaiser Permanente Northern California
    Oct 5, 2023

    COVID-19, Renal Insufficiency, Chronic Trial in Beijing (Nirmatrelvir/ritonavir)

    Recruiting
    • COVID-19
    • Renal Insufficiency, Chronic
    • Beijing, Beijing, China
      Chinese PLA General Hospital
    Jul 6, 2023

    Long COVID-19, Long COVID Trial (Paxlovid 25 day dosing, Paxlovid 15 day dosing, Control)

    Not yet recruiting
    • Long COVID-19
    • Long COVID
    • Paxlovid 25 day dosing
    • +2 more
    • (no location specified)
    Jul 25, 2023

    Post-acute Sequelae of SARS-CoV-2 Infection, Long COVID Trial in Stanford (Nirmatrelvir, Placebo, Ritonavir)

    Recruiting
    • Post-acute Sequelae of SARS-CoV-2 Infection
    • Long COVID
    • Stanford, California
      Stanford University
    Dec 12, 2022

    Learn About the COVID-19 Prescribed Paxlovid in Morocco

    Not yet recruiting
    • COVID-19 Drug Treatment
    • (no location specified)
    Aug 15, 2023

    SARS-CoV-2 Infection Trial in Hohhot (Azvudine, Paxlovid group)

    Recruiting
    • SARS-CoV-2 Infection
    • Hohhot, Inner Mongolia, China
      Hohhot First Hospital
    Dec 7, 2022

    Paxlovid Once in Market, to Observe Its Safety and Effectiveness

    Not yet recruiting
    • COVID-19
      • (no location specified)
      Jun 2, 2023

      A Prospective Monitoring Study for Those Individuals Treated

      Enrolling by invitation
      • COVID-19
        • San Diego, California
          Scripps Research Institute
        Nov 14, 2022

        General Investigation for PAXLOVID PACK

        Recruiting
        • SARS-CoV-2 Infection
        • nirmatrelvir / ritonavir
        • Tokyo, Japan
          Pfizer Local County
        May 12, 2022

        COVID-19, Uremia Trial (Paxlovid, standard-of-care)

        Not yet recruiting
        • COVID-19
        • Uremia
        • (no location specified)
        May 20, 2022

        COVID-19 Trial in Shanghai (Paxlovid)

        Recruiting
        • COVID-19
        • Paxlovid
        • Shanghai, China
          Huashan Hospital Affiliated to Fudan University
        May 23, 2022

        Healthy Trial in Cairo (Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose), Nirmatrelvir 150 mg + Ritonavir 100 mg

        Recruiting
        • Healthy
        • Nirmatrelvir 150 mg + Ritonavir 100 mg (Reference first dose)
        • +2 more
        • Cairo, Egypt
          Genuine Research Center GRC
        Aug 4, 2022

        COVID-19 Trial in Shanghai (JT001, Paxlovid)

        Completed
        • COVID-19
        • Shanghai, Shanghai, China
        • +6 more
        Sep 18, 2022

        Safety Issues Trial in Shanghai (Nirmatrelvir and ritonavir stage 1, Nirmatrelvir and ritonavir stage 2)

        Completed
        • Safety Issues
        • Nirmatrelvir and ritonavir stage 1
        • Nirmatrelvir and ritonavir stage 2
        • Shanghai, Shanghai, China
          Department of Nephrology, Renji Hospital, Shanghai JiaoTong Univ
        Jun 12, 2022

        COVID-19, Immunodeficiency Trial (Paxlovid 5 days, Paxlovid 10 days, Tixagevimab and Cilgavimab)

        Not yet recruiting
        • COVID-19
        • Immunodeficiency
        • Paxlovid 5 days
        • +2 more
        • (no location specified)
        Oct 18, 2022

        Healthcare Resource Use Among COVID-19 Patients Receiving

        Not yet recruiting
        • Covid-19
        • nirmatrelvir, ritonavir
        • Riyadh, Saudi Arabia
          Saudi Arabia
        Aug 25, 2023

        Real World COVID-19 Antiviral Effectiveness Research

        Not yet recruiting
        • COVID-19
        • Oral Antiviral
        • (no location specified)
        Dec 4, 2022

        Mesenchymal Stem Cell, COVID-19 Pneumonia Trial in Shanghai (umbilical cord mesenchymal stem cells, paxlovid)

        Recruiting
        • Mesenchymal Stem Cell
        • COVID-19 Pneumonia
        • umbilical cord mesenchymal stem cells
        • paxlovid
        • Shanghai, Shanghai, China
          Shanghai East Hospital, Shanghai Tongji University
        Jan 10, 2023

        Long COVID Trial (Paxlovid, Placebo)

        Not yet recruiting
        • Long COVID
        • Paxlovid
        • Placebo
        • (no location specified)
        Oct 24, 2022

        Nirmatrelvir-ritonavir in Hospitalized Patients

        Recruiting
        • Hospitalized Patients
        • Hangzhou, Zhejiang, China
          Changcheng Shi
        Feb 26, 2023

        COVID-19 Trial in Toronto (Paxlovid, Other)

        Not yet recruiting
        • COVID-19
        • Toronto, Ontario, Canada
          Unity Health Toronto
        Nov 9, 2022

        Effectiveness and Safety of New Oral Antivirals for COVID-19

        Recruiting
        • COVID-19
        • Açores, Portugal
        • +5 more
        Jun 12, 2023